BioPharma Dive - Latest News

Merck takes $200M tariff hit, trimming its gross profits

The drugmaker absorbed additional tariff-related costs in the first quarter, but has taken steps to lower the financial impact it’ll have for the rest of the year and beyond. 

Apr 24, 2025 - 16:45
 0
Merck takes $200M tariff hit, trimming its gross profits

The drugmaker absorbed additional tariff-related costs in the first quarter, but has taken steps to lower the financial impact it’ll have for the rest of the year and beyond. 

Read More

Tags:

Previous Article

Lowering blood pressure reduces dementia risk in patients with hypertension, lar...

Next Article

Spin-related and non-spin-related effects of magnetic fields on water oxidation

Related Posts

Vertex challenger Sionna prices $191M IPO

Vertex challenger Sionna prices $191M IPO

Feb 9, 2025  0

Duchenne patient dies after receiving Sarepta gene therapy

Duchenne patient dies after receiving Sarepta gene therapy

Mar 18, 2025  0

Solid says early data suggest ‘differentiated’ Duchenne gene therapy

Solid says early data suggest ‘differentiated’ Duchenne...

Feb 18, 2025  0